Kiniksa Pharmaceuticals International (KNSA) Goodwill & Intangibles (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Goodwill & Intangibles came in at $14.8 million in Q2 2026, down 6.35% YoY from $15.8 million in Q2 2025, and down 1.67% on a QoQ basis from $15.0 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Goodwill & Intangibles data on file, last reported at $14.8 million in Q2 2026.
- Quarterly Goodwill & Intangibles fell 6.35% year-over-year to $14.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.8 million (down 6.35% YoY) and the FY2025 annual result came in at $15.2 million, down 23.75% from the prior year.
- Goodwill & Intangibles eased to $14.8 million in Q2 2026, from $15.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $20.0 million in Q1 2022 to a low of $14.8 million in Q2 2026.
- A 5-year average of $17.8 million and a median of $17.2 million in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles changed 0.0% — and 2025, when it declined 23.75%.
- Tracing KNSA's Goodwill & Intangibles over 5 years: stood at $20.0 million in 2022, then changed by 0.0% to $20.0 million in 2023, then changed by 0.0% to $20.0 million in 2024, then declined by 23.75% to $15.2 million in 2025, then slipped by 3.28% to $14.8 million in 2026.
- The last three Goodwill & Intangibles figures came in at $14.8 million (Q2 2026), $15.0 million (Q1 2026), and $15.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.08 Bn | 5.56 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.75 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Sep 30, 2025 | 15.50 Mn |
| Jun 30, 2025 | 15.75 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 16.50 Mn |
| Jun 30, 2024 | 16.75 Mn |
| Mar 31, 2024 | 17.00 Mn |
| Dec 31, 2023 | 20.00 Mn |
| Sep 30, 2023 | 17.50 Mn |
| Jun 30, 2023 | 20.00 Mn |
| Mar 31, 2023 | 20.00 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 20.00 Mn |
| Mar 31, 2022 | 20.00 Mn |
| Dec 31, 2021 | 20.00 Mn |
| Sep 30, 2021 | 20.00 Mn |